Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriers

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):294-9. doi: 10.1176/jnp.23.3.jnp294.

Abstract

It is not known whether apolipoprotein E ε4-an Alzheimer disease susceptibility gene-influences the effects of state-anxiety on executive functioning in healthy individuals. In a prospective cohort study of 185 cognitively normal individuals, there were ε4 homozygotes, heterozygotes, and non-carriers, who did not differ in age, sex, years of education, cognitive test scores, psychotropic medications, and state- or trait-anxiety. However, higher anxiety was associated with significantly worse Trails B performance in the ε4 homozygotes, as compared with ε4 non-carriers. The association of executive-functioning difficulties and anxiety appears more likely to occur in persons who are most at risk for subsequent cognitive decline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Analysis of Variance
  • Anxiety / complications*
  • Anxiety / genetics*
  • Apolipoprotein E4 / genetics*
  • Cognition Disorders / etiology*
  • Cognition Disorders / genetics*
  • Cohort Studies
  • Executive Function
  • Female
  • Homozygote*
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests

Substances

  • Apolipoprotein E4